Jonathan Quick
Corporate Officer/Principal chez LOGICBIO THERAPEUTICS, INC.
Postes actifs de Jonathan Quick
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| Comptroller/Controller/Auditor | 31/12/2020 | 11/01/2021 | |
| Directeur Financier/CFO | 01/04/2019 | - |
Historique de carrière de Jonathan Quick
Anciens postes connus de Jonathan Quick
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formation de Jonathan Quick
| Providence College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Jonathan Quick
- Expérience
